Laidlaw served as Sole Book-Runner on the $14,375,000 Offering for Evoke Pharma (EVOK)
Laidlaw Capital Markets is pleased to have acted as the Sole Book-Runner on the $14,375,000 Follow-On Offering for Evoke Pharma (EVOK). Evoke has been a partner for years now and we are excited for their Read More...
The “Laidlaw Five” 2020 Forecasts
Tech - Cloud Computing Growth Remains Solid, But Quality Control Issues Threaten Tech Majors: One of the major shifts of interest to investors has been that of enterprise computing to "cloud" platforms. In this regard, there have been three major competitors - AMZN, GOOGL & MSFT. While GOOGL results won't be out until after the close Mon 10/28, the indications from AMZN (AWS 3Q19 revenues $9bn, +34.7% year/year vs. +37% y/y in 2Q19) and MSFT (Commercial Cloud 3Q19 revenues $11.6bn, +36% y/y) indicate that while cloud adoption growth is decelerating from earlier levels, it still remains quite solid. With major growth areas such as cloud computing remaining robust, the near-term prospects for the tech sector remain positive...
Laidlaw served as Financial Advisor on the $11.5mm Beyond Air (XAIR) Follow-On Offering
The Laidlaw Capital Markets team is pleased to announce our role as a Financial Advisor to Beyond Air Inc (XAIR) on this mornings $11,500,000 Follow-On Offering led by Suntrust Robinson. Laidlaw acted as Sole Placement Read More...
Stay In Touch